Prevalence of Anti-Ganglioside Antibodies and Their Clinical Correlates with Guillain-Barré Syndrome in Korea: A Nationwide Multicenter Study
No previous studies have investigated the relationship between various anti-ganglioside antibodies and the clinical characteristics of Guillain-Barré syndrome (GBS) in Korea. The aim of this study was to determine the prevalence and types of anti-ganglioside antibodies in Korean GBS patients, and to...
Saved in:
Published in | Journal of clinical neurology (Seoul, Korea) Vol. 10; no. 2; pp. 94 - 100 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
Korean Neurological Association
01.04.2014
대한신경과학회 |
Subjects | |
Online Access | Get full text |
ISSN | 1738-6586 2005-5013 |
DOI | 10.3988/jcn.2014.10.2.94 |
Cover
Abstract | No previous studies have investigated the relationship between various anti-ganglioside antibodies and the clinical characteristics of Guillain-Barré syndrome (GBS) in Korea. The aim of this study was to determine the prevalence and types of anti-ganglioside antibodies in Korean GBS patients, and to identify their clinical significance.
Serum was collected from patients during the acute phase of GBS at 20 university-based hospitals in Korea. The clinical and laboratory findings were reviewed and compared with the detected types of anti-ganglioside antibody.
Among 119 patients, 60 were positive for immunoglobulin G (IgG) or immunoglobulin M antibodies against any type of ganglioside (50%). The most frequent type was IgG anti-GM1 antibody (47%), followed by IgG anti-GT1a (38%), IgG anti-GD1a (25%), and IgG anti-GQ1b (8%) antibodies. Anti-GM1-antibody positivity was strongly correlated with the presence of preceding gastrointestinal infection, absence of sensory symptoms or signs, and absence of cranial nerve involvement. Patients with anti-GD1a antibody were younger, predominantly male, and had more facial nerve involvement than the antibody-negative group. Anti-GT1a-antibody positivity was more frequently associated with bulbar weakness and was highly associated with ophthalmoplegia when coupled with the coexisting anti-GQ1b antibody. Despite the presence of clinical features of acute motor axonal neuropathy (AMAN), 68% of anti-GM1- or anti-GD1a-antibody-positive cases of GBS were diagnosed with acute inflammatory demyelinating polyradiculoneuropathy (AIDP) by a single electrophysiological study.
Anti-ganglioside antibodies were frequently found in the serum of Korean GBS patients, and each antibody was correlated strongly with the various clinical manifestations. Nevertheless, without an anti-ganglioside antibody assay, in Korea AMAN is frequently misdiagnosed as AIDP by single electrophysiological studies. |
---|---|
AbstractList | Background and Purpose No previous studies have investigated the relationship betweenvarious anti-ganglioside antibodies and the clinical characteristics of Guillain-Barré syndrome(GBS) in Korea. The aim of this study was to determine the prevalence and types of anti-ganglioside antibodies in Korean GBS patients, and to identify their clinical significance.
Methods Serum was collected from patients during the acute phase of GBS at 20 universitybased hospitals in Korea. The clinical and laboratory findings were reviewed and compared withthe detected types of anti-ganglioside antibody.
Results Among 119 patients, 60 were positive for immunoglobulin G (IgG) or immunoglobulin M antibodies against any type of ganglioside (50%). The most frequent type was IgG anti-GM1 antibody (47%), followed by IgG anti-GT1a (38%), IgG anti-GD1a (25%), and IgG anti-GQ1b (8%) antibodies. Anti-GM1-antibody positivity was strongly correlated with the presenceof preceding gastrointestinal infection, absence of sensory symptoms or signs, and absence ofcranial nerve involvement. Patients with anti-GD1a antibody were younger, predominantlymale, and had more facial nerve involvement than the antibody-negative group. Anti-GT1a-antibody positivity was more frequently associated with bulbar weakness and was highly associated with ophthalmoplegia when coupled with the coexisting anti-GQ1b antibody. Despite the presence of clinical features of acute motor axonal neuropathy (AMAN), 68% of anti-GM1- oranti-GD1a-antibody-positive cases of GBS were diagnosed with acute inflammatory demyelinating polyradiculoneuropathy (AIDP) by a single electrophysiological study.
Conclusions Anti-ganglioside antibodies were frequently found in the serum of KoreanGBS patients, and each antibody was correlated strongly with the various clinical manifestations. Nevertheless, without an anti-ganglioside antibody assay, in Korea AMAN is frequentlymisdiagnosed as AIDP by single electrophysiological studies. KCI Citation Count: 41 No previous studies have investigated the relationship between various anti-ganglioside antibodies and the clinical characteristics of Guillain-Barré syndrome (GBS) in Korea. The aim of this study was to determine the prevalence and types of anti-ganglioside antibodies in Korean GBS patients, and to identify their clinical significance. Serum was collected from patients during the acute phase of GBS at 20 university-based hospitals in Korea. The clinical and laboratory findings were reviewed and compared with the detected types of anti-ganglioside antibody. Among 119 patients, 60 were positive for immunoglobulin G (IgG) or immunoglobulin M antibodies against any type of ganglioside (50%). The most frequent type was IgG anti-GM1 antibody (47%), followed by IgG anti-GT1a (38%), IgG anti-GD1a (25%), and IgG anti-GQ1b (8%) antibodies. Anti-GM1-antibody positivity was strongly correlated with the presence of preceding gastrointestinal infection, absence of sensory symptoms or signs, and absence of cranial nerve involvement. Patients with anti-GD1a antibody were younger, predominantly male, and had more facial nerve involvement than the antibody-negative group. Anti-GT1a-antibody positivity was more frequently associated with bulbar weakness and was highly associated with ophthalmoplegia when coupled with the coexisting anti-GQ1b antibody. Despite the presence of clinical features of acute motor axonal neuropathy (AMAN), 68% of anti-GM1- or anti-GD1a-antibody-positive cases of GBS were diagnosed with acute inflammatory demyelinating polyradiculoneuropathy (AIDP) by a single electrophysiological study. Anti-ganglioside antibodies were frequently found in the serum of Korean GBS patients, and each antibody was correlated strongly with the various clinical manifestations. Nevertheless, without an anti-ganglioside antibody assay, in Korea AMAN is frequently misdiagnosed as AIDP by single electrophysiological studies. No previous studies have investigated the relationship between various anti-ganglioside antibodies and the clinical characteristics of Guillain-Barré syndrome (GBS) in Korea. The aim of this study was to determine the prevalence and types of anti-ganglioside antibodies in Korean GBS patients, and to identify their clinical significance.BACKGROUND AND PURPOSENo previous studies have investigated the relationship between various anti-ganglioside antibodies and the clinical characteristics of Guillain-Barré syndrome (GBS) in Korea. The aim of this study was to determine the prevalence and types of anti-ganglioside antibodies in Korean GBS patients, and to identify their clinical significance.Serum was collected from patients during the acute phase of GBS at 20 university-based hospitals in Korea. The clinical and laboratory findings were reviewed and compared with the detected types of anti-ganglioside antibody.METHODSSerum was collected from patients during the acute phase of GBS at 20 university-based hospitals in Korea. The clinical and laboratory findings were reviewed and compared with the detected types of anti-ganglioside antibody.Among 119 patients, 60 were positive for immunoglobulin G (IgG) or immunoglobulin M antibodies against any type of ganglioside (50%). The most frequent type was IgG anti-GM1 antibody (47%), followed by IgG anti-GT1a (38%), IgG anti-GD1a (25%), and IgG anti-GQ1b (8%) antibodies. Anti-GM1-antibody positivity was strongly correlated with the presence of preceding gastrointestinal infection, absence of sensory symptoms or signs, and absence of cranial nerve involvement. Patients with anti-GD1a antibody were younger, predominantly male, and had more facial nerve involvement than the antibody-negative group. Anti-GT1a-antibody positivity was more frequently associated with bulbar weakness and was highly associated with ophthalmoplegia when coupled with the coexisting anti-GQ1b antibody. Despite the presence of clinical features of acute motor axonal neuropathy (AMAN), 68% of anti-GM1- or anti-GD1a-antibody-positive cases of GBS were diagnosed with acute inflammatory demyelinating polyradiculoneuropathy (AIDP) by a single electrophysiological study.RESULTSAmong 119 patients, 60 were positive for immunoglobulin G (IgG) or immunoglobulin M antibodies against any type of ganglioside (50%). The most frequent type was IgG anti-GM1 antibody (47%), followed by IgG anti-GT1a (38%), IgG anti-GD1a (25%), and IgG anti-GQ1b (8%) antibodies. Anti-GM1-antibody positivity was strongly correlated with the presence of preceding gastrointestinal infection, absence of sensory symptoms or signs, and absence of cranial nerve involvement. Patients with anti-GD1a antibody were younger, predominantly male, and had more facial nerve involvement than the antibody-negative group. Anti-GT1a-antibody positivity was more frequently associated with bulbar weakness and was highly associated with ophthalmoplegia when coupled with the coexisting anti-GQ1b antibody. Despite the presence of clinical features of acute motor axonal neuropathy (AMAN), 68% of anti-GM1- or anti-GD1a-antibody-positive cases of GBS were diagnosed with acute inflammatory demyelinating polyradiculoneuropathy (AIDP) by a single electrophysiological study.Anti-ganglioside antibodies were frequently found in the serum of Korean GBS patients, and each antibody was correlated strongly with the various clinical manifestations. Nevertheless, without an anti-ganglioside antibody assay, in Korea AMAN is frequently misdiagnosed as AIDP by single electrophysiological studies.CONCLUSIONSAnti-ganglioside antibodies were frequently found in the serum of Korean GBS patients, and each antibody was correlated strongly with the various clinical manifestations. Nevertheless, without an anti-ganglioside antibody assay, in Korea AMAN is frequently misdiagnosed as AIDP by single electrophysiological studies. |
Author | Sohn, Eun Hee Lee, Su-Yun Kusunoki, Susumu Park, Young-Eun Huh, So Young Oh, Sun-Young Kim, Ji Soo Song, Hyun Seok Kim, Sun Young Suh, Bum Chun Kim, Jong Eun Lee, Tae-Kyeong Kim, Nam-Hee Choi, Young-Chul Bae, Jong Seok Nam, Tai-Seung Kim, Jong Kuk Jeong, Seong-Hae Kwon, Ohyun Kim, Dae-Seong Lim, Jeong-Geun Park, Min Su Kim, Dong Uk Lee, Sung-Hoon Park, Ki-Jong |
AuthorAffiliation | q Department of Neurology, College of Medicine, Konyang University, Daejeon, Korea g Department of Neurology, School of Medicine, Gyeongsang National University, Jinju, Korea e Department of Industrial and Occupational Medicine, Pusan National University School of Medicine, Busan, Korea c Department of Neurology, School of Medicine, Pusan National University, Busan, Korea v Department of Neurology, School of Medicine, Chosun University, Gwangju, Korea o Department of Neurology, College of Medicine, Yonsei University, Seoul, Korea u Department of Neurology, College of Medicine, Soonchunhyang University, Seoul, Korea a Department of Neurology, College of Medicine, Dong-A University, Busan, Korea f Department of Neurology, College of Medicine, Seoul National University, Seoul, Korea j Department of Neurology, School of Medicine, Keimyung University, Daegu, Korea i Department of Neurology, College of Medicine, University of Ulsan, Ulsan, Korea s Department of Neurology, School of Medicine, Eulji Univ |
AuthorAffiliation_xml | – name: c Department of Neurology, School of Medicine, Pusan National University, Busan, Korea – name: j Department of Neurology, School of Medicine, Keimyung University, Daegu, Korea – name: t Department of Neurology, School of Medicine, Chonbuk National University, Jeonju, Korea – name: g Department of Neurology, School of Medicine, Gyeongsang National University, Jinju, Korea – name: r Department of Neurology, College of Medicine, Kosin University, Busan, Korea – name: m Department of Neurology, Chonnam National University Medical School, Gwangju, Korea – name: f Department of Neurology, College of Medicine, Seoul National University, Seoul, Korea – name: o Department of Neurology, College of Medicine, Yonsei University, Seoul, Korea – name: k Department of Neurology, College of Medicine, Dongguk University, Seoul, Korea – name: a Department of Neurology, College of Medicine, Dong-A University, Busan, Korea – name: h Department of Neurology, School of Medicine, Kyungpook National University, Daegu, Korea – name: e Department of Industrial and Occupational Medicine, Pusan National University School of Medicine, Busan, Korea – name: d Department of Neurology, School of Medicine, Kinki University, Osaka, Japan – name: i Department of Neurology, College of Medicine, University of Ulsan, Ulsan, Korea – name: p Department of Neurology, School of Medicine, Chungnam National University, Daejeon, Korea – name: n Department of Neurology, School of Medicine, Yeungnam University, Daegu, Korea – name: u Department of Neurology, College of Medicine, Soonchunhyang University, Seoul, Korea – name: q Department of Neurology, College of Medicine, Konyang University, Daejeon, Korea – name: l Department of Neurology, School of Medicine, Sungkyunkwan University, Seoul, Korea – name: b Department of Neurology, College of Medicine, Hallym University, Seoul, Korea – name: s Department of Neurology, School of Medicine, Eulji University, Seoul, Korea – name: v Department of Neurology, School of Medicine, Chosun University, Gwangju, Korea |
Author_xml | – sequence: 1 givenname: Jong Kuk surname: Kim fullname: Kim, Jong Kuk organization: Department of Neurology, College of Medicine, Dong-A University, Busan, Korea – sequence: 2 givenname: Jong Seok surname: Bae fullname: Bae, Jong Seok organization: Department of Neurology, College of Medicine, Hallym University, Seoul, Korea – sequence: 3 givenname: Dae-Seong surname: Kim fullname: Kim, Dae-Seong organization: Department of Neurology, School of Medicine, Pusan National University, Busan, Korea – sequence: 4 givenname: Susumu surname: Kusunoki fullname: Kusunoki, Susumu organization: Department of Neurology, School of Medicine, Kinki University, Osaka, Japan – sequence: 5 givenname: Jong Eun surname: Kim fullname: Kim, Jong Eun organization: Department of Industrial and Occupational Medicine, Pusan National University School of Medicine, Busan, Korea – sequence: 6 givenname: Ji Soo surname: Kim fullname: Kim, Ji Soo organization: Department of Neurology, College of Medicine, Seoul National University, Seoul, Korea – sequence: 7 givenname: Young-Eun surname: Park fullname: Park, Young-Eun organization: Department of Neurology, School of Medicine, Pusan National University, Busan, Korea – sequence: 8 givenname: Ki-Jong surname: Park fullname: Park, Ki-Jong organization: Department of Neurology, School of Medicine, Gyeongsang National University, Jinju, Korea – sequence: 9 givenname: Hyun Seok surname: Song fullname: Song, Hyun Seok organization: Department of Neurology, School of Medicine, Kyungpook National University, Daegu, Korea – sequence: 10 givenname: Sun Young surname: Kim fullname: Kim, Sun Young organization: Department of Neurology, College of Medicine, University of Ulsan, Ulsan, Korea – sequence: 11 givenname: Jeong-Geun surname: Lim fullname: Lim, Jeong-Geun organization: Department of Neurology, School of Medicine, Keimyung University, Daegu, Korea – sequence: 12 givenname: Nam-Hee surname: Kim fullname: Kim, Nam-Hee organization: Department of Neurology, College of Medicine, Dongguk University, Seoul, Korea – sequence: 13 givenname: Bum Chun surname: Suh fullname: Suh, Bum Chun organization: Department of Neurology, School of Medicine, Sungkyunkwan University, Seoul, Korea – sequence: 14 givenname: Tai-Seung surname: Nam fullname: Nam, Tai-Seung organization: Department of Neurology, Chonnam National University Medical School, Gwangju, Korea – sequence: 15 givenname: Min Su surname: Park fullname: Park, Min Su organization: Department of Neurology, School of Medicine, Yeungnam University, Daegu, Korea – sequence: 16 givenname: Young-Chul surname: Choi fullname: Choi, Young-Chul organization: Department of Neurology, College of Medicine, Yonsei University, Seoul, Korea – sequence: 17 givenname: Eun Hee surname: Sohn fullname: Sohn, Eun Hee organization: Department of Neurology, School of Medicine, Chungnam National University, Daejeon, Korea – sequence: 19 givenname: So Young surname: Huh fullname: Huh, So Young organization: Department of Neurology, College of Medicine, Kosin University, Busan, Korea – sequence: 20 givenname: Ohyun surname: Kwon fullname: Kwon, Ohyun organization: Department of Neurology, School of Medicine, Eulji University, Seoul, Korea – sequence: 21 givenname: Su-Yun surname: Lee fullname: Lee, Su-Yun organization: Department of Neurology, College of Medicine, Dong-A University, Busan, Korea – sequence: 22 givenname: Sung-Hoon surname: Lee fullname: Lee, Sung-Hoon organization: Department of Neurology, College of Medicine, Hallym University, Seoul, Korea – sequence: 23 givenname: Sun-Young surname: Oh fullname: Oh, Sun-Young organization: Department of Neurology, School of Medicine, Chonbuk National University, Jeonju, Korea – sequence: 24 givenname: Seong-Hae surname: Jeong fullname: Jeong, Seong-Hae organization: Department of Neurology, School of Medicine, Chungnam National University, Daejeon, Korea – sequence: 25 givenname: Tae-Kyeong surname: Lee fullname: Lee, Tae-Kyeong organization: Department of Neurology, College of Medicine, Soonchunhyang University, Seoul, Korea – sequence: 26 givenname: Dong Uk surname: Kim fullname: Kim, Dong Uk organization: Department of Neurology, School of Medicine, Chosun University, Gwangju, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24829594$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001863399$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp1Ustu1DAUtVARnRb2rJCXbDL4ETsxC6RhBENFeYgOa8txnI5bjz04Tqv5Cf6D7-DHcDKUl8TGV7r3PK6uzwk48sEbAB5jNKeirp9daT8nCJfz3CBzUd4DM4IQKxjC9AjMcEXrgrOaH4OTvr9CiFeoxg_AMSlrIpgoZ-Drx2hulDNeGxg6uPDJFivlL50NvW3N1GhCa00PlW_hemNshEtnvdXKwWWI0TiV8vTWpg1cDdY5ZX3xUsX4_Ru82Ps2hq2B1sO3IRr1HC7ge5Vs8Lej-rvBJauNTybCizS0-4fgfqdcbx79rKfg8-tX6-Wb4vzD6my5OC90SUQqSiYEoxXlTY3zo6tOdR3GpaC047rETScoN0KYtmpbhllDWcWailSsY5lV01Pw9KDrYyevtZVB2aleBnkd5eLT-kySGjPBM_TFAbobmq1px22jcnIX7VbF_UT8e-LtJsvcyBLhChH222sXw5fB9Eluba9NPpQ3YeglZoRVnCOBM_TJn16_TO7-KwP4AaBj6PtoOqltmu6Zra2TGMkxGDIHQ47BGBtETkT0D_FO-7-UH8MQveY |
CitedBy_id | crossref_primary_10_3390_vaccines11020425 crossref_primary_10_7759_cureus_55000 crossref_primary_10_3988_jcn_2018_14_3_401 crossref_primary_10_1111_jns_12612 crossref_primary_10_18214_jkaem_2014_16_1_7 crossref_primary_10_1016_j_jocn_2015_11_034 crossref_primary_10_3390_medicina55050177 crossref_primary_10_3988_jcn_2019_15_3_308 crossref_primary_10_17340_jkna_2022_3_8 crossref_primary_10_18700_jnc_180073 crossref_primary_10_1016_j_clineuro_2015_10_022 crossref_primary_10_14253_acn_2018_20_1_49 crossref_primary_10_1080_21645515_2018_1493415 crossref_primary_10_1111_jns_12208 crossref_primary_10_1136_bcr_2014_205336 crossref_primary_10_1002_mus_27126 crossref_primary_10_1097_CND_0000000000000109 crossref_primary_10_1016_j_neuarg_2020_01_004 crossref_primary_10_4103_aian_aian_121_22 crossref_primary_10_46518_kjnmd_2021_13_2_67 crossref_primary_10_1136_jnnp_2017_316930 crossref_primary_10_1080_01616412_2021_1948750 crossref_primary_10_3341_jkos_2017_58_2_197 crossref_primary_10_1038_s41598_018_37572_w crossref_primary_10_1212_NXI_0000000000000284 crossref_primary_10_12677_ACM_2020_107180 crossref_primary_10_3988_jcn_2019_15_3_404 crossref_primary_10_3389_fnagi_2022_831890 crossref_primary_10_14253_acn_2019_21_1_53 crossref_primary_10_2169_internalmedicine_55_6881 crossref_primary_10_3389_fneur_2022_902172 crossref_primary_10_18214_jend_2023_00150 crossref_primary_10_3988_jcn_2016_12_4_495 crossref_primary_10_1002_acn3_50828 crossref_primary_10_1007_s13760_021_01787_y crossref_primary_10_13078_jksrs_14007 crossref_primary_10_3988_jcn_2021_17_2_257 crossref_primary_10_1111_ene_12885 crossref_primary_10_4103_aian_AIAN_823_20 crossref_primary_10_1111_jns_12115 crossref_primary_10_3988_jcn_2017_13_4_442 crossref_primary_10_1007_s00415_024_12410_4 crossref_primary_10_12729_jbr_2014_15_3_141 crossref_primary_10_1038_s41598_019_52643_2 crossref_primary_10_1111_ene_16365 crossref_primary_10_14253_acn_2022_24_1_17 crossref_primary_10_1016_j_arcped_2016_02_019 crossref_primary_10_1515_revneuro_2023_0024 crossref_primary_10_1097_WCO_0000000000000242 crossref_primary_10_1097_WCO_0000000000000361 crossref_primary_10_1016_j_pediatrneurol_2025_03_007 crossref_primary_10_1155_2015_564098 crossref_primary_10_1517_21678707_2015_1043266 crossref_primary_10_17340_jkna_2019_1_2 crossref_primary_10_1186_s43161_024_00258_8 crossref_primary_10_46518_kjnmd_2021_13_2_40 crossref_primary_10_1136_jnnp_2020_323960 crossref_primary_10_3988_jcn_2021_17_2_322 crossref_primary_10_1016_j_jns_2022_120512 crossref_primary_10_1002_cti2_1437 crossref_primary_10_14253_acn_2020_22_2_112 crossref_primary_10_1016_j_clineuro_2015_04_025 crossref_primary_10_1016_j_it_2022_02_003 crossref_primary_10_1016_j_neuarg_2020_11_002 crossref_primary_10_3346_jkms_2017_32_7_1154 crossref_primary_10_1007_s13760_020_01592_z crossref_primary_10_1111_jns_12614 crossref_primary_10_18787_jr_2023_00011 crossref_primary_10_1212_WNL_0000000000002256 crossref_primary_10_1016_j_jns_2019_116576 crossref_primary_10_1136_pn_2022_003438 |
Cites_doi | 10.1111/j.1529-8027.2011.00314.x 10.1093/brain/118.3.597 10.1002/ana.410270707 10.1002/ana.1012 10.1002/ana.410350510 10.1093/brain/awf258 10.1002/mus.20762 10.1002/ana.410310619 10.1002/1531-8249(200010)48:4<624::AID-ANA9>3.0.CO;2-O 10.1007/s00415-009-5254-8 10.1002/glia.20503 10.1016/S0022-510X(99)00097-0 10.1093/brain/awf272 10.1111/j.1471-4159.2007.04718.x 10.1002/ana.410390404 10.1016/S0140-6736(78)92644-2 10.1016/j.jocn.2012.02.035 10.1016/j.jns.2004.01.005 10.1016/S0140-6736(05)67665-9 10.1136/jnnp.65.5.799 10.1136/jnnp.66.4.513 10.1002/ana.410440512 10.1002/mus.880170504 10.1136/jnnp.2010.208538 10.1111/j.1468-1331.2004.00975.x 10.1136/jnnp.70.1.50 10.1016/j.clineuro.2012.03.024 10.1002/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6 10.1212/01.wnl.0000324266.95814.74 10.1016/S0165-5728(98)00016-2 10.1136/jnnp-2011-300309 10.1212/WNL.56.9.1227 10.1001/archneur.64.10.1519 10.1523/JNEUROSCI.4401-06.2007 10.1002/ana.410440210 |
ContentType | Journal Article |
Copyright | Copyright © 2014 Korean Neurological Association 2014 |
Copyright_xml | – notice: Copyright © 2014 Korean Neurological Association 2014 |
DBID | AAYXX CITATION NPM 7X8 5PM ACYCR |
DOI | 10.3988/jcn.2014.10.2.94 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2005-5013 |
EndPage | 100 |
ExternalDocumentID | oai_kci_go_kr_ARTI_281596 PMC4017025 24829594 10_3988_jcn_2014_10_2_94 |
Genre | Journal Article |
GrantInformation_xml | – fundername: Dong-A University |
GroupedDBID | 29K 2WC 5-W 5GY 8JR 8XY 9ZL AAKDD AAYXX ACYCR ADBBV ADRAZ AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION D-I DIK DU5 E3Z EF. F5P GROUPED_DOAJ HYE KQ8 M48 OK1 PGMZT RPM NPM 7X8 5PM |
ID | FETCH-LOGICAL-c429t-459953736b8136bc7faff114933f6c41bf936e99ed7dd515b3575b7275f573683 |
IEDL.DBID | M48 |
ISSN | 1738-6586 |
IngestDate | Sun Mar 09 07:59:57 EDT 2025 Thu Aug 21 14:14:02 EDT 2025 Fri Jul 11 01:07:21 EDT 2025 Thu Apr 03 07:02:52 EDT 2025 Tue Jul 01 03:10:46 EDT 2025 Thu Apr 24 22:59:10 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | antibodies acute motor axonal neuropathy Guillain-Barré syndrome ganglioside Korea |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c429t-459953736b8136bc7faff114933f6c41bf936e99ed7dd515b3575b7275f573683 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 G704-002236.2014.10.2.011 http://dx.doi.org/10.3988/jcn.2014.10.2.94 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3988/jcn.2014.10.2.94 |
PMID | 24829594 |
PQID | 1525766091 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_281596 pubmedcentral_primary_oai_pubmedcentral_nih_gov_4017025 proquest_miscellaneous_1525766091 pubmed_primary_24829594 crossref_citationtrail_10_3988_jcn_2014_10_2_94 crossref_primary_10_3988_jcn_2014_10_2_94 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-04-01 |
PublicationDateYYYYMMDD | 2014-04-01 |
PublicationDate_xml | – month: 04 year: 2014 text: 2014-04-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Journal of clinical neurology (Seoul, Korea) |
PublicationTitleAlternate | J Clin Neurol |
PublicationYear | 2014 |
Publisher | Korean Neurological Association 대한신경과학회 |
Publisher_xml | – name: Korean Neurological Association – name: 대한신경과학회 |
References | Willison (10.3988/jcn.2014.10.2.94_ref25) 2007; 103 Ogawara (10.3988/jcn.2014.10.2.94_ref22) 2000; 48 Odaka (10.3988/jcn.2014.10.2.94_ref23) 1999; 165 Kuwabara (10.3988/jcn.2014.10.2.94_ref34) 1998; 44 Willison (10.3988/jcn.2014.10.2.94_ref17) 2002; 125 Kim (10.3988/jcn.2014.10.2.94_ref33) 2013; 20 Yuki (10.3988/jcn.2014.10.2.94_ref5) 2007; 35 Koga (10.3988/jcn.2014.10.2.94_ref13) 1999; 66 Nagashima (10.3988/jcn.2014.10.2.94_ref12) 2007; 64 Susuki (10.3988/jcn.2014.10.2.94_ref30) 2009; 256 Yuki (10.3988/jcn.2014.10.2.94_ref4) 2001; 49 Hong (10.3988/jcn.2014.10.2.94_ref36) 2011; 16 Uncini (10.3988/jcn.2014.10.2.94_ref7) 2010; 81 Gong (10.3988/jcn.2014.10.2.94_ref31) 2002; 125 Paparounas (10.3988/jcn.2014.10.2.94_ref14) 2004; 61 Hadden (10.3988/jcn.2014.10.2.94_ref19) 1998; 44 Hughes (10.3988/jcn.2014.10.2.94_ref2) 2005; 366 Chiba (10.3988/jcn.2014.10.2.94_ref16) 1992; 31 Ho (10.3988/jcn.2014.10.2.94_ref24) 1999; 45 Ho (10.3988/jcn.2014.10.2.94_ref20) 1995; 118 Kusunoki (10.3988/jcn.2014.10.2.94_ref11) 1994; 35 Oh (10.3988/jcn.2014.10.2.94_ref21) 1994; 17 Asbury (10.3988/jcn.2014.10.2.94_ref1) 1990; 27 Kusunoki (10.3988/jcn.2014.10.2.94_ref3) 1996; 39 Nagashima (10.3988/jcn.2014.10.2.94_ref9) 2004; 219 Odaka (10.3988/jcn.2014.10.2.94_ref15) 2001; 70 Koga (10.3988/jcn.2014.10.2.94_ref29) 1998; 86 Kim (10.3988/jcn.2014.10.2.94_ref35) 2012; 114 Sekiguchi (10.3988/jcn.2014.10.2.94_ref6) 2012; 83 Galassi (10.3988/jcn.2014.10.2.94_ref32) 2004; 11 Miyazaki (10.3988/jcn.2014.10.2.94_ref10) 2001; 56 Lee (10.3988/jcn.2014.10.2.94_ref8) 2008; 71 Hughes (10.3988/jcn.2014.10.2.94_ref18) 1978; 2 Susuki (10.3988/jcn.2014.10.2.94_ref26) 2007; 27 Kashihara (10.3988/jcn.2014.10.2.94_ref28) 1998; 65 Susuki (10.3988/jcn.2014.10.2.94_ref27) 2007; 55 9708542 - Ann Neurol. 1998 Aug;44(2):202-8 11118247 - J Neurol Neurosurg Psychiatry. 2001 Jan;70(1):50-5 10450797 - J Neurol Sci. 1999 Jun 1;165(2):126-32 9655474 - J Neuroimmunol. 1998 Jun 1;86(1):74-9 22010183 - J Neurol Neurosurg Psychiatry. 2012 Jan;83(1):23-8 1514781 - Ann Neurol. 1992 Jun;31(6):677-9 11026446 - Ann Neurol. 2000 Oct;48(4):624-31 12390975 - Brain. 2002 Nov;125(Pt 11):2491-506 23164827 - J Clin Neurosci. 2013 Mar;20(3):473-5 2194422 - Ann Neurol. 1990;27 Suppl:S21-4 11409422 - Ann Neurol. 2001 Jun;49(6):712-20 8159178 - Muscle Nerve. 1994 May;17(5):489-93 80682 - Lancet. 1978 Oct 7;2(8093):750-3 9810965 - J Neurol Neurosurg Psychiatry. 1998 Nov;65(5):799 17923636 - Arch Neurol. 2007 Oct;64(10):1519-23 11342695 - Neurology. 2001 May 8;56(9):1227-9 7600081 - Brain. 1995 Jun;118 ( Pt 3):597-605 17986149 - J Neurochem. 2007 Nov;103 Suppl 1:143-9 15525304 - Eur J Neurol. 2004 Nov;11(11):790-1 15262730 - Arch Neurol. 2004 Jul;61(7):1013-6 15050449 - J Neurol Sci. 2004 Apr 15;219(1-2):139-45 17428969 - J Neurosci. 2007 Apr 11;27(15):3956-67 9818934 - Ann Neurol. 1998 Nov;44(5):780-8 16271648 - Lancet. 2005 Nov 5;366(9497):1653-66 22503060 - Clin Neurol Neurosurg. 2012 Dec;114(10):1345-7 17352383 - Glia. 2007 May;55(7):746-57 18678825 - Neurology. 2008 Aug 5;71(6):426-9 12429589 - Brain. 2002 Dec;125(Pt 12):2591-625 8179303 - Ann Neurol. 1994 May;35(5):570-6 19633904 - J Neurol. 2009 Nov;256(11):1899-905 21504501 - J Peripher Nerv Syst. 2011 Mar;16(1):37-46 8619520 - Ann Neurol. 1996 Apr;39(4):424-31 9989618 - Ann Neurol. 1999 Feb;45(2):168-73 20870864 - J Neurol Neurosurg Psychiatry. 2010 Oct;81(10):1157-63 17373701 - Muscle Nerve. 2007 Jun;35(6):691-711 10201426 - J Neurol Neurosurg Psychiatry. 1999 Apr;66(4):513-6 |
References_xml | – volume: 16 start-page: 37 year: 2011 ident: 10.3988/jcn.2014.10.2.94_ref36 publication-title: J Peripher Nerv Syst doi: 10.1111/j.1529-8027.2011.00314.x – volume: 118 start-page: 597 issue: Pt 3 year: 1995 ident: 10.3988/jcn.2014.10.2.94_ref20 publication-title: Brain doi: 10.1093/brain/118.3.597 – volume: 27 start-page: S21 issue: Suppl year: 1990 ident: 10.3988/jcn.2014.10.2.94_ref1 publication-title: Ann Neurol doi: 10.1002/ana.410270707 – volume: 49 start-page: 712 year: 2001 ident: 10.3988/jcn.2014.10.2.94_ref4 publication-title: Ann Neurol doi: 10.1002/ana.1012 – volume: 35 start-page: 570 year: 1994 ident: 10.3988/jcn.2014.10.2.94_ref11 publication-title: Ann Neurol doi: 10.1002/ana.410350510 – volume: 125 start-page: 2491 issue: Pt 11 year: 2002 ident: 10.3988/jcn.2014.10.2.94_ref31 publication-title: Brain doi: 10.1093/brain/awf258 – volume: 35 start-page: 691 year: 2007 ident: 10.3988/jcn.2014.10.2.94_ref5 publication-title: Muscle Nerve doi: 10.1002/mus.20762 – volume: 31 start-page: 677 year: 1992 ident: 10.3988/jcn.2014.10.2.94_ref16 publication-title: Ann Neurol doi: 10.1002/ana.410310619 – volume: 48 start-page: 624 year: 2000 ident: 10.3988/jcn.2014.10.2.94_ref22 publication-title: Ann Neurol doi: 10.1002/1531-8249(200010)48:4<624::AID-ANA9>3.0.CO;2-O – volume: 256 start-page: 1899 year: 2009 ident: 10.3988/jcn.2014.10.2.94_ref30 publication-title: J Neurol doi: 10.1007/s00415-009-5254-8 – volume: 55 start-page: 746 year: 2007 ident: 10.3988/jcn.2014.10.2.94_ref27 publication-title: Glia doi: 10.1002/glia.20503 – volume: 165 start-page: 126 year: 1999 ident: 10.3988/jcn.2014.10.2.94_ref23 publication-title: J Neurol Sci doi: 10.1016/S0022-510X(99)00097-0 – volume: 125 start-page: 2591 issue: Pt 12 year: 2002 ident: 10.3988/jcn.2014.10.2.94_ref17 publication-title: Brain doi: 10.1093/brain/awf272 – volume: 103 start-page: 143 issue: Suppl 1 year: 2007 ident: 10.3988/jcn.2014.10.2.94_ref25 publication-title: J Neurochem doi: 10.1111/j.1471-4159.2007.04718.x – volume: 39 start-page: 424 year: 1996 ident: 10.3988/jcn.2014.10.2.94_ref3 publication-title: Ann Neurol doi: 10.1002/ana.410390404 – volume: 2 start-page: 750 year: 1978 ident: 10.3988/jcn.2014.10.2.94_ref18 publication-title: Lancet doi: 10.1016/S0140-6736(78)92644-2 – volume: 20 start-page: 473 year: 2013 ident: 10.3988/jcn.2014.10.2.94_ref33 publication-title: J Clin Neurosci doi: 10.1016/j.jocn.2012.02.035 – volume: 219 start-page: 139 year: 2004 ident: 10.3988/jcn.2014.10.2.94_ref9 publication-title: J Neurol Sci doi: 10.1016/j.jns.2004.01.005 – volume: 366 start-page: 1653 year: 2005 ident: 10.3988/jcn.2014.10.2.94_ref2 publication-title: Lancet doi: 10.1016/S0140-6736(05)67665-9 – volume: 65 start-page: 799 year: 1998 ident: 10.3988/jcn.2014.10.2.94_ref28 publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.65.5.799 – volume: 66 start-page: 513 year: 1999 ident: 10.3988/jcn.2014.10.2.94_ref13 publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.66.4.513 – volume: 44 start-page: 780 year: 1998 ident: 10.3988/jcn.2014.10.2.94_ref19 publication-title: Ann Neurol doi: 10.1002/ana.410440512 – volume: 17 start-page: 489 year: 1994 ident: 10.3988/jcn.2014.10.2.94_ref21 publication-title: Muscle Nerve doi: 10.1002/mus.880170504 – volume: 81 start-page: 1157 year: 2010 ident: 10.3988/jcn.2014.10.2.94_ref7 publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.2010.208538 – volume: 11 start-page: 790 year: 2004 ident: 10.3988/jcn.2014.10.2.94_ref32 publication-title: Eur J Neurol doi: 10.1111/j.1468-1331.2004.00975.x – volume: 70 start-page: 50 year: 2001 ident: 10.3988/jcn.2014.10.2.94_ref15 publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.70.1.50 – volume: 114 start-page: 1345 year: 2012 ident: 10.3988/jcn.2014.10.2.94_ref35 publication-title: Clin Neurol Neurosurg doi: 10.1016/j.clineuro.2012.03.024 – volume: 45 start-page: 168 year: 1999 ident: 10.3988/jcn.2014.10.2.94_ref24 publication-title: Ann Neurol doi: 10.1002/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6 – volume: 71 start-page: 426 year: 2008 ident: 10.3988/jcn.2014.10.2.94_ref8 publication-title: Neurology doi: 10.1212/01.wnl.0000324266.95814.74 – volume: 86 start-page: 74 year: 1998 ident: 10.3988/jcn.2014.10.2.94_ref29 publication-title: J Neuroimmunol doi: 10.1016/S0165-5728(98)00016-2 – volume: 83 start-page: 23 year: 2012 ident: 10.3988/jcn.2014.10.2.94_ref6 publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2011-300309 – volume: 56 start-page: 1227 year: 2001 ident: 10.3988/jcn.2014.10.2.94_ref10 publication-title: Neurology doi: 10.1212/WNL.56.9.1227 – volume: 64 start-page: 1519 year: 2007 ident: 10.3988/jcn.2014.10.2.94_ref12 publication-title: Arch Neurol doi: 10.1001/archneur.64.10.1519 – volume: 27 start-page: 3956 year: 2007 ident: 10.3988/jcn.2014.10.2.94_ref26 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.4401-06.2007 – volume: 61 start-page: 1013 year: 2004 ident: 10.3988/jcn.2014.10.2.94_ref14 publication-title: Arch Neurol – volume: 44 start-page: 202 year: 1998 ident: 10.3988/jcn.2014.10.2.94_ref34 publication-title: Ann Neurol doi: 10.1002/ana.410440210 – reference: 22010183 - J Neurol Neurosurg Psychiatry. 2012 Jan;83(1):23-8 – reference: 18678825 - Neurology. 2008 Aug 5;71(6):426-9 – reference: 15525304 - Eur J Neurol. 2004 Nov;11(11):790-1 – reference: 7600081 - Brain. 1995 Jun;118 ( Pt 3):597-605 – reference: 2194422 - Ann Neurol. 1990;27 Suppl:S21-4 – reference: 23164827 - J Clin Neurosci. 2013 Mar;20(3):473-5 – reference: 15050449 - J Neurol Sci. 2004 Apr 15;219(1-2):139-45 – reference: 17373701 - Muscle Nerve. 2007 Jun;35(6):691-711 – reference: 17923636 - Arch Neurol. 2007 Oct;64(10):1519-23 – reference: 8619520 - Ann Neurol. 1996 Apr;39(4):424-31 – reference: 1514781 - Ann Neurol. 1992 Jun;31(6):677-9 – reference: 8159178 - Muscle Nerve. 1994 May;17(5):489-93 – reference: 9989618 - Ann Neurol. 1999 Feb;45(2):168-73 – reference: 15262730 - Arch Neurol. 2004 Jul;61(7):1013-6 – reference: 20870864 - J Neurol Neurosurg Psychiatry. 2010 Oct;81(10):1157-63 – reference: 19633904 - J Neurol. 2009 Nov;256(11):1899-905 – reference: 17428969 - J Neurosci. 2007 Apr 11;27(15):3956-67 – reference: 11342695 - Neurology. 2001 May 8;56(9):1227-9 – reference: 12390975 - Brain. 2002 Nov;125(Pt 11):2491-506 – reference: 16271648 - Lancet. 2005 Nov 5;366(9497):1653-66 – reference: 9655474 - J Neuroimmunol. 1998 Jun 1;86(1):74-9 – reference: 17352383 - Glia. 2007 May;55(7):746-57 – reference: 11118247 - J Neurol Neurosurg Psychiatry. 2001 Jan;70(1):50-5 – reference: 9708542 - Ann Neurol. 1998 Aug;44(2):202-8 – reference: 80682 - Lancet. 1978 Oct 7;2(8093):750-3 – reference: 10201426 - J Neurol Neurosurg Psychiatry. 1999 Apr;66(4):513-6 – reference: 12429589 - Brain. 2002 Dec;125(Pt 12):2591-625 – reference: 11026446 - Ann Neurol. 2000 Oct;48(4):624-31 – reference: 17986149 - J Neurochem. 2007 Nov;103 Suppl 1:143-9 – reference: 9810965 - J Neurol Neurosurg Psychiatry. 1998 Nov;65(5):799 – reference: 22503060 - Clin Neurol Neurosurg. 2012 Dec;114(10):1345-7 – reference: 9818934 - Ann Neurol. 1998 Nov;44(5):780-8 – reference: 21504501 - J Peripher Nerv Syst. 2011 Mar;16(1):37-46 – reference: 10450797 - J Neurol Sci. 1999 Jun 1;165(2):126-32 – reference: 8179303 - Ann Neurol. 1994 May;35(5):570-6 – reference: 11409422 - Ann Neurol. 2001 Jun;49(6):712-20 |
SSID | ssj0067081 |
Score | 2.2205374 |
Snippet | No previous studies have investigated the relationship between various anti-ganglioside antibodies and the clinical characteristics of Guillain-Barré syndrome... Background and Purpose No previous studies have investigated the relationship betweenvarious anti-ganglioside antibodies and the clinical characteristics of... |
SourceID | nrf pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 94 |
SubjectTerms | Original 신경과학 |
Title | Prevalence of Anti-Ganglioside Antibodies and Their Clinical Correlates with Guillain-Barré Syndrome in Korea: A Nationwide Multicenter Study |
URI | https://www.ncbi.nlm.nih.gov/pubmed/24829594 https://www.proquest.com/docview/1525766091 https://pubmed.ncbi.nlm.nih.gov/PMC4017025 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001863399 |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Journal of Clinical Neurology, 2014, 10(2), , pp.94-100 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3bTtwwELW4SFVfKkov0Atypb70wVs2cewYqaq2qEBbbV_KSrxZtmNDysqBsCvgJ_of_Y7-WGeSsGXRCqkviZL4kmTszJnM-Awhb3OujPC5ZSF4wXjuPbMwcFgQDr6EQcng0KM7_C4ORvzrUXb0b3l09wIvFpp2mE9qVI97V-fXH2HCf0CLU4EB99MhkWmf9zCuuaf4MlkFvSTQFBvymU9ByO0mZWlfwhQHvds5LRe2MKeklmMdFuHPu2GUt_TS3hp51AFKOmhHwGOy5OM6eTDsXOZPyC8kaTLN0iJaBTqIk5LtG1y8W2GmzuaErTCWkJpY0EN0HNCOLXRMdzF5xxjxKMU_tnR_ilmKysg-mbr-85v-6AgPaBnptwoA6A4d0JZr-xJbb9b34p37mmLI4vVTMtr7fLh7wLokDMyBqpowjoxkqUyFzfuwcTKYEMCIUmkK8uR9G1QqvFK-kEUB4MimAAAtoKIsZFArT5-RlVhFv0GoyYJ0CZjcPAPc4qwRiSu2QyrzgkNjfJO8v3nr2nUM5ZgoY6zBUkE5aZCTRjnhiUQrqPFuVuOsZee4p-wbEKQ-daVGSm3cH1f6tNZgOHzRSQ64TkCZGzFrmGboOzHRV9MLjWmipBCArjbJ81bssx4Tnicqwx7k3ICYFcD-5q_E8qSh8uZIX5RkL_7jOV6Sh3jYRg-9IiuTeupfAzCa2K3mh8JWM-r_Agi1DX0 |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+of+Anti-Ganglioside+Antibodies+and+Their+Clinical+Correlates+with+Guillain-Barr%C3%A9+Syndrome+in+Korea%3A+A+Nationwide+Multicenter+Study&rft.jtitle=Journal+of+clinical+neurology+%28Seoul%2C+Korea%29&rft.au=Kim%2C+Jong+Kuk&rft.au=Bae%2C+Jong+Seok&rft.au=Kim%2C+Dae-Seong&rft.au=Kusunoki%2C+Susumu&rft.date=2014-04-01&rft.issn=1738-6586&rft.eissn=2005-5013&rft.volume=10&rft.issue=2&rft.spage=94&rft_id=info:doi/10.3988%2Fjcn.2014.10.2.94&rft.externalDBID=n%2Fa&rft.externalDocID=10_3988_jcn_2014_10_2_94 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1738-6586&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1738-6586&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1738-6586&client=summon |